✦ LIBER ✦

Clinical results of treating type 2 diabetic patients with sitagliptin, vildagliptin or saxagliptin – diabetes control and potential adverse events

✍ Scribed by Bo Ahrén

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Glycaemic control and adverse events in

✍ J. Belsey; G. Krishnarajah 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB

Safety and efficacy of treatment with si

✍ T. Seck; M. Nauck; D. Sheng; S. Sunga; M. J. Davies; P. P. Stein; K. D. Kaufman; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB

PDB4 A CROSS-SECTIONAL STUDY ON GLYCEMIC

✍ SL Hu; F Sun; ZR Xu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

Effects of pioglitazone on major adverse

✍ Robert Wilcox; Stuart Kupfer; Erland Erdmann 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 201 KB

Pharmacokinetics, Pharmacodynamics, and

✍ Sanwald-Ducray, P; Liogier D'ardhuy, X; Jamois, C; Banken, L 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 184 KB

Initial therapy with the fixed-dose comb

✍ J. Wainstein; L. Katz; S. S. Engel; L. Xu; G. T. Golm; S. Hussain; E. A. O’Neill 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 624 KB